1 Stanley Druckenmiller Ultragenyx Pharmaceutical Trades
Stanley Druckenmiller acquired 85.4 Thousand Ultragenyx Pharmaceutical shares worth $3.17 Million. That's 0.09% of their equity portfolio (45th largest holding). The investor's estimated purchase price is $4.35 Million, resulting in a loss of 27%.